The Hindu·2 min read·medium
Sun Pharma gets nod from South African regulator for generic semaglutide injection
P
PTI
✦AI Summary
Sun Pharmaceutical Industries has received approval from South African regulators to manufacture and market a generic version of the semaglutide injection. The drug, used for treating type 2 diabetes, will be available as a pre-filled, multi-dose injectable pen.
Sun Pharmaceutical Industries Ltd. on Wednesday (July 15, 2026) said it has received approval from the South African regulator to manufacture and market a generic version of semaglutide injection in the country for treatment of adults with type 2 diabetes mellitus.
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in